AddLife AB (publ) (ALIF-B) - Total Liabilities
Based on the latest financial reports, AddLife AB (publ) (ALIF-B) has total liabilities worth Skr7.51 Billion SEK (≈ $808.30 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of AddLife AB (publ) to see how much of total assets are deployed in long-term investments.
AddLife AB (publ) - Total Liabilities Trend (2012–2025)
This chart illustrates how AddLife AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ALIF-B total asset value.
AddLife AB (publ) Competitors by Total Liabilities
The table below lists competitors of AddLife AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dalian Zeus Entertainment
SHE:002354
|
China | CN¥648.57 Million |
|
Shanghai Flyco Electrical Appliance Co Ltd
SHG:603868
|
China | CN¥624.18 Million |
|
Chongqing Fuling Electric Power Industrial Co Ltd
SHG:600452
|
China | CN¥731.84 Million |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥4.62 Billion |
|
China Enterprise Co Ltd
SHG:600675
|
China | CN¥34.01 Billion |
|
OKE Precision Cutting Tools Co. Ltd. A
SHG:688308
|
China | CN¥1.26 Billion |
|
Progyny Inc
NASDAQ:PGNY
|
USA | $262.58 Million |
|
Jiamei Food Packaging Chuzhou Co
SHE:002969
|
China | CN¥1.13 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down AddLife AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See AddLife AB (publ) (ALIF-B) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AddLife AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AddLife AB (publ) (2012–2025)
The table below shows the annual total liabilities of AddLife AB (publ) from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr7.26 Billion ≈ $781.72 Million |
-6.22% |
| 2024-12-31 | Skr7.75 Billion ≈ $833.59 Million |
-0.50% |
| 2023-12-31 | Skr7.79 Billion ≈ $837.79 Million |
-3.72% |
| 2022-12-31 | Skr8.09 Billion ≈ $870.18 Million |
+28.25% |
| 2021-12-31 | Skr6.30 Billion ≈ $678.50 Million |
+179.06% |
| 2020-12-31 | Skr2.26 Billion ≈ $243.14 Million |
+25.64% |
| 2019-12-31 | Skr1.80 Billion ≈ $193.52 Million |
+3.58% |
| 2018-12-31 | Skr1.74 Billion ≈ $186.83 Million |
+51.85% |
| 2017-12-31 | Skr1.14 Billion ≈ $123.04 Million |
+32.97% |
| 2016-12-31 | Skr859.80 Million ≈ $92.53 Million |
-7.60% |
| 2015-12-31 | Skr930.50 Million ≈ $100.14 Million |
+144.87% |
| 2014-12-31 | Skr380.00 Million ≈ $40.89 Million |
+11.24% |
| 2013-12-31 | Skr341.60 Million ≈ $36.76 Million |
+8.24% |
| 2012-12-31 | Skr315.60 Million ≈ $33.96 Million |
-- |
About AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical resear… Read more